Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
The intraocular route of drug administration enables the delivery of high concentrations of therapeutic drugs, while minimizing their systemic absorption. Several drugs are administered into the anterior chamber or vitreous, and the intraocular injection has been effective in curing various intraocular diseases. Rabbit eyes have been widely used for ophthalmic research, as the animal is easy to handle and economical compared to other mammals, and the size of a rabbit eye is similar to that of a human eye. Using a 30 G needle, drugs can be injected into the intracameral and intravitreal spaces of rabbit eyes. The eyeballs are then frozen until analysis, and can be divided into the aqueous humor, vitreous, and retina/choroid. The vitreous and retina/choroid samples can be homogenized and solubilized before analysis. Then, immunoassays can be performed to measure the concentrations of intraocular drugs in each compartment. Appropriate pharmacokinetic models can be used to calculate several parameters, such as the half-life and maximum concentration of the drug. Rabbit eyes can be a good model for pharmacokinetic studies of intraocular drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This enrichment highlights the rabbit’s known ocular sensitivity and its established role as a preclinical model for ocular toxicity assessment, especially in biologic drug development (Ahn et al., 2016; Bussing and Shah, 2020; Sokolowski et al., 2024).”
From A large-scale concordance study of toxicity findings across preclinical species and humans for small molecules and biologics (2026) · cites this paper as Ahn et al., 2016
Citations
Cites
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
(2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102673 · Cited by 2,669
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
The Diabetic Retinopathy Clinical Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414264 · Cited by 1,607
Ranibizumab for Macular Edema following Central Retinal Vein Occlusion
Brown, D. M., Campochiaro, P. A., Singh, R. P., Li, Z., Gray, S., Saroj, N., Rundle, A. C., Rubio, R. G., & Murahashi, W. Y. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.022 · Cited by 1,155
Boyer, D. S., Yoon, Y. H., Belfort, R., Bandello, F., Maturi, R. K., Augustin, A. J., Li, X.-Y., Cui, H., Hashad, Y., & Whitcup, S. M. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.04.024 · Cited by 1,122
Challenges and obstacles of ocular pharmacokinetics and drug delivery
Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.027 · Cited by 1,003
Campochiaro, P. A., Brown, D. M., Awh, C. C., Lee, S. Y., Gray, S., Saroj, N., Murahashi, W. Y., & Rubio, R. G. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.02.038 · Cited by 711
Haller, J. A., Bandello, F., Belfort, R., Blumenkranz, M. S., Gillies, M., Heier, J., Loewenstein, A., Yoon, Y. H., Jiao, J., Li, X.-Y., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.05.014 · Cited by 673
RISKS OF INTRAVITREOUS INJECTION: A COMPREHENSIVE REVIEW
JAGER, R. D., AIELLO, L. P., PATEL, S. C., & CUNNINGHAM, E. T. (2004) · Retina · doi:10.1097/00006982-200410000-00002 · Cited by 572
Pharmacokinetics of Intravitreal Ranibizumab (Lucentis)
Bakri, S. J., Snyder, M. R., Reid, J. M., Pulido, J. S., Ezzat, M. K., & Singh, R. J. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.09.012 · Cited by 541
Research works printed but not linked: 4
- Barza, M. Animal models in evaluation of chemotherapy of ocular infections. In: Zak O, Sande MA, eds. Experimental Models in Antimicrobial Chemotherapy. 187-211 Harcourt Brace Jovanovich, (1986).
- Maurice, D. M., Mishima, S. Ocular pharmacokinetics. Vol. 69 Springer Verlag, (1984).
- Ruby, A. J., Williams, G. A., Blumenkranz, M. S. Vitreous humor. In: Foundations of Clinical Ophthalmology. Lippincott Williams & Wilkins, (2006).
- Jaffe, G. J., Ashton, P., Andrew, P. Intraocular Drug Delivery. Taylor & Francis, (2006). · doi:10.3109/9781420016505
Cited by
Nanotechnology-based ocular drug delivery systems: recent advances and future prospects
Li, S., Chen, L., & Fu, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01992-2 · Cited by 277
“In addition, Restasis ® (CsA), Eysuvis ® (loteprednol eta-bonate), Lacrisek ® (vitamin A palmitate and vitamin E), Cyclokat ® (CsA) and Artelac Rebalance ® (vitamin B12) are also used for the therapy of DED [22, 23].”
BackgroundOcular Drug Delivery to the Retina: Current Innovations and Future Perspectives
Kim, H. M., & Woo, S. J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010108 · Cited by 198
Self-citationChallenges and opportunities for drug delivery to the posterior of the eye
Cabrera, F. J., Wang, D. C., Reddy, K., Acharya, G. S., & Shin, C. S. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.05.035 · Cited by 133
“However, rabbit eyes produce more mucus, blink less, and produce fewer tears compared with human eyes [14,64].”
BackgroundOcular Delivery of Therapeutic Proteins: A Review
Shastri, D. H., Silva, A. C., & Almeida, H. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010205 · Cited by 60
Shen, Y., Sun, J., & Sun, X. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01838-x · Cited by 50
Fu, Y., Zhang, Z., Webster, K. A., & Paulus, Y. M. (2024) · Biomolecules · doi:10.3390/biom14030252 · Cited by 45
“Consequently, physiologic manipulation technologies developed for human eyes can be applied to rabbits with minimal modification [52–54].”
BackgroundRafael, D. F. D. S., Guerrero, M., Maricán, A., Arango, D., Sarmento, B. F. C. C., Ferrer, R., Durán‐Lara, E. F., Clark, S. J., & Schwartz, S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051484 · Cited by 41
Fan, X., Jiang, K., Geng, F., Lu, W., & Wei, G. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114864 · Cited by 33
Suprachoroidal delivery enables targeting, localization and durability of small molecule suspensions
Kansara, V. S., Hancock, S. E., Muya, L. W., & Ciulla, T. A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.05.061 · Cited by 27
Gene Editing in Rabbits: Unique Opportunities for Translational Biomedical Research
Xu, J., Zhang, J., Yang, D., Song, J. W., Pallas, B. D., Zhang, C., Hu, J., Peng, X., Christensen, N. D., Han, R., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.642444 · Cited by 24
“Rabbits have been used successfully as models for clinical, morphological and mechanistic studies of both common and rare ocular diseases, including DES, glaucoma, AMD, light-induced retinopathies, cataracts and uveitis, diabetic retinopathy, retinal detachment and proliferative vitreoretinopathy, ocular allergy, reti…”
MethodAbbasi, M., Aghamollaei, H., Vaez, A., Amani, A. M., Kamyab, H., Chelliapan, S., Jamalpour, S., & Zambrano-Dávila, R. (2025) · The Ocular Surface · doi:10.1016/j.jtos.2025.03.004 · Cited by 23
Rad, I. J., Chapman, L., Tupally, K. R., Veidt, M., Alsadiq, H., Sullivan, R., & Parekh, H. S. (2023) · Theranostics · doi:10.7150/thno.82884 · Cited by 23
“3 μl and 50-55 μl of mice and rats, respectively (Figure 9, Table 7) [146].”
BackgroundRole of the Fc Region in the Vitreous Half-Life of Anti-VEGF Drugs
Joo, K., Park, S. J., Choi, Y., Lee, J. E., Na, Y. M., Hong, H. K., Park, K. H., Kim, H. M., Chung, J., & Woo, S. J. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-21813 · Cited by 22
“The equations and detailed parameters used for pharmacokinetic modeling and analysis were described previously.(8,17) The half-life of elimination (t1/2), mean residence time (MRT), observed maximum concentration (Cmax), area under the concentration–time curve (AUC), apparent volume of distribution (Vd/F), and apparen…”
MethodSelf-citationSarwar, A. R., Iqbal, F. M., Jamil, M. A., & Abbas, K. (2023) · Molecules · doi:10.3390/molecules28155918 · Cited by 20
PET study of ocular and blood pharmacokinetics of intravitreal bevacizumab and aflibercept in rats
Luaces-Rodríguez, A., del Amo, E. M., Mondelo‐García, C., Gómez‐Lado, N., González, F., Ruibal, Á., González‐Barcia, M., Zarra‐Ferro, I., Otero-Espinar, F. J., Fernández‐Ferreiro, A., et al. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.06.024 · Cited by 19
Scleral ultrastructure and biomechanical changes in rabbits after negative lens application
Lin, X., Wang, B., Wang, Y.-C., Chu, R., Dai, J., Zhou, X., Qu, X., Liu, H. S., & Zhou, H. (2018) · International Journal of Ophthalmology · doi:10.18240/ijo.2018.03.02 · Cited by 18
Araujo, N. L., Lacerda, A. D. J., Mendonça, M. A., da Silva, A. P. D. S. M., Neto, F. D. A. D., Portela, R. W., & Oriá, A. P. (2020) · Optometry and Vision Science · doi:10.1097/opx.0000000000001583 · Cited by 18
“Rabbits are frequently chosen as an experimental model in the study of ocular diseases(8,9) and are used for the development of different ophthalmic formulations and approaches used in human and veterinary medicine.(10,11) This species is used in human ocular research because it is easy to work with, promptly availabl…”
BackgroundExploring rabbit as a nonrodent species for general toxicology studies
Sokolowski, K., Turner, P. V., Lewis, E., Wange, R. L., & Fortin, M. C. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae022 · Cited by 17
Chockalingam, A., Xu, L., Stewart, S. R., Merdy, M. L., Tsakalozou, E., Fan, J., Patel, V. P., & Rouse, R. L. (2018) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2018.12.002 · Cited by 17
Dexamethasone delivery to the ocular posterior segment by sustained-release Laponite formulation
Prieto, E., Cardiel, M. J., Vispe, E., Idoipe, M., García‐Martín, E., Fraile, J. M., Polo, V., Mayoral, J. A., Pablo, L. E., & Rodrigo, M. J. (2020) · Biomedical Materials · doi:10.1088/1748-605x/aba445 · Cited by 18
Kelani, K. M., Hegazy, M. A. M., Hassan, A. M., & Tantawy, M. A. (2021) · RSC Advances · doi:10.1039/d0ra10598h · Cited by 15
PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model
García‐Otero, X., Mondelo‐García, C., Bandín‐Vilar, E., Gómez‐Lado, N., Silva‐Rodríguez, J., Rey‐Bretal, D., Otero-Espinar, V., Adán, A., González‐Barcia, M., Aguiar, P., et al. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122261 · Cited by 15
Sheibani, N., Zaitoun, I. S., Wang, S., Darjatmoko, S. R., Suscha, A., Song, Y., Sorenson, C. M., Shifrin, V. I., Albert, D. M., Melgar-Asensio, I., et al. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108030 · Cited by 15
“4 mL average of estimated IVT rabbit volumes (Ahn et al., 2016), we proposed a 400-fold proportional dose in rabbit vs.”
BackgroundAge differential response to bevacizumab therapy in choroidal neovascularization in rabbits
Nguyen, V. P., Henry, J., Zhe, J., Kieu, Q., Qian, W. P., Fu, Y., Wang, X., & Paulus, Y. M. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.109215 · Cited by 15
Hussein, O. G., Rostom, Y., Abdelkawy, M. A. A., Rezk, M. R., & Ahmed, D. A. (2023) · Journal of Chromatographic Science · doi:10.1093/chromsci/bmad042 · Cited by 14
Schubert, W., Terjung, C., Rafique, A., Romano, C., Ellinger, P., & Rittenhouse, K. D. (2022) · Translational Vision Science & Technology · doi:10.1167/tvst.11.10.36 · Cited by 11
Gogoi, N. R., Marbaniang, D., Pal, P., Ray, S., & Mazumder, B. (2022) · Pharmaceutical Nanotechnology · doi:10.2174/2211738510666220806102612 · Cited by 10
Song, H., Zeng, Y., Sardar Pasha, S. P. B., Bush, R. A., Vijayasarathy, C., Qian, H., Wei, L., Wiley, H. E., Wu, Z., & Sieving, P. A. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.7.28 · Cited by 9
da Silva, P. H. R., de Castro, M. A., Ribeiro, M. C. S., Gonçalves, L. T. A., de Melo, L. A., Marques, M. B. D. F., Pedrosa, T. A., Pianetti, G. A., Fialho, S. L., Yoshida, M. I., et al. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125507 · Cited by 9
Lee, S. M., Park, J. H., Jang, C. H., & Byon, I. S. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108614 · Cited by 8
Erdal, E., Bakıcı, C., Arslan, A., Batur, B., Yaman, M. E., Alçığır, M. E., Akyol, M., Ekim, O., Salih, B., & Uğurlu, N. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123336 · Cited by 8
Rawat, P. S., Ravi, P. R., & Mahajan, R. R. (2024) · Discover Nano · doi:10.1186/s11671-024-04109-2 · Cited by 8
“An ocular pharmacokinetic study was conducted to determine the rate and extent of NEB absorption in aqueous humor, while a pharmacodynamic study was conducted to measure the percent change in intraocular pressure (% ΔIOP) in a male New Zealand rabbit as an animal model [18].”
MethodChowdhury, J. M., Ruiz, E. A. C., Ohr, M. P., Swindle‐Reilly, K. E., & Versypt, A. N. F. (2024) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2024.12.005 · Cited by 8
Shivva, V., Boswell, C. A., Rafidi, H., Kelley, R. F., Kamath, A. V., & Crowell, S. R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.601569 · Cited by 7
“Rabbit was chosen as the test system since it is the most commonly used preclinical species for evaluating ocular pharmacokinetics of biologics (Del Amo and Urtti, 2015; Ahn et al., 2016; Del Amo et al., 2017).”
BackgroundMethodKim, Y. Y., Kim, J., Che, J., Ku, S., Kang, B.-C., & Yun, J.-W. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020130 · Cited by 6
Muñoz‐Villegas, P., Sánchez‐Ríos, A., Quiñonez-Alvarado, M. G., Olvera‐Montaño, O., Quintana-Hau, J. D. D., & Baiza-Durán, L. M. (2021) · Journal of Experimental Pharmacology · doi:10.2147/jep.s308388 · Cited by 6
“The vitreous humor (VH) was obtained following a previously published method.(16) Frozen vitreous was then completely extracted from the eye and was kept frozen at −80°C until analysis.”
MethodHassan, S. A., Mahmoud, A. M., Kamel, M. A., Abbas, S. S., & Michael, A. M. (2023) · Current Analytical Chemistry · doi:10.2174/1573411019666230213105056 · Cited by 7
Eom, Y., Kim, S.-M., Huh, J., Koh, M., Hwang, J. Y., Kang, B., Li, X., Lee, M. S., Lee, H., Kim, H. M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-96561-8 · Cited by 6
Hu, T., Zhou, T., Goit, R. K., Tam, K. C., Chan, Y. K., Lam, W.-C., & Lo, A. (2024) · Marine Drugs · doi:10.3390/md22090394 · Cited by 5
Erb, C., Topouzis, F., Jayaram, H., Allan, F., Nisslé, S., Muñoz-Negrete, F. J., & Stalmans, I. (2024) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2024.0092 · Cited by 5
Chromatographic bioanalysis of antiglaucoma drugs in ocular tissues
da Silva, P. H. R., Silva‐Cunha, A., Pianetti, G. A., & Fernandes, C. (2020) · Journal of Chromatography B · doi:10.1016/j.jchromb.2020.122388 · Cited by 6
Prat, I. T., Ganza, Á., Hernández, G., Gonzalo, A., & Zazpe, A. (2022) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2022.0024 · Cited by 5
Liu, X., & Fan, F. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2026.1731947 · Cited by 4
Nonclinical Similarity of the Biosimilar Candidate ABP 938 with Aflibercept Reference Product
Seo, N., Kuhns, S. T., Andrews, D. A., Colbert, A., Chow, V., & Liu, J. (2024) · Ophthalmology and Therapy · doi:10.1007/s40123-024-01043-5 · Cited by 4
“Additionally, the rabbit eye is sufficiently large to allow for IVT drug delivery [25, 44].”
Collagenase-modified polydopamine nanoparticles for safe and effective vitreolysis
Minnaert, A., Nguyen, V. P., Harizaj, A., Goemaere, I., Puyvelde, B. V., Dhaenens, M., Sauvage, F., Deforce, D. L. D., Salmaso, S., Caliceti, P., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113753 · Cited by 4
Comparative morphological evaluation of animal corneal parameters
Babrauskienė, V., Žymantienė, J., Aniulienë, A., Juozaitienė, V., Malakauskienė, S., & Alionienė, J. I. (2018) · Medycyna Weterynaryjna · doi:10.21521/mw.6010 · Cited by 4
“Rabbit eyes can be a good model for pharmacokinetic studies of intraocular drugs (1).”
Backgroundda Silva, P. H. R., de Castro, M. A., Ribeiro, M. C. S., Ferreira, E. D., Gonçalves, J. E., Pianetti, G. A., Fialho, S. L., Silva‐Cunha, A., & Fernandes, C. (2024) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2024.116458 · Cited by 3
Ubani-Ukoma, U. N., Enisenyin, O. A., Oyewale, O. J., & Nwankwo, P. A. (2025) · Nigerian Journal of Pharmaceutical Research · doi:10.4314/njpr.v20i2.7 · Cited by 2
“Due to the similarity of rabbit eyes to human eyes, rabbits are widely used in ophthalmic research (Ahn et al ., 2016) and most times large number of these animals are required.”
Johnson, C., Maier, E. Y., Bhalla, A., Crowell, E. L., Wang, Y., Qin, B., & Zhang, F. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c01076 · Cited by 3
Fan, X., Harding, P. A., Ziaei, P., Chaudhry, A. B., West, R. E., Nolin, T. D., & Fedorchak, M. V. (2025) · Translational Vision Science & Technology · doi:10.1167/tvst.14.7.15 · Cited by 1
Caruso, A., Mittag, J. J., Dengl, S., Mundigl, O., Wessels, U., Crowell, S. R., Brömel, T. C., Funk, J., Hartmann, T., Steiner, G., et al. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00120 · Cited by 1
Block, M., Giorgio, G., Saal, C., Bakker, R. A., Göpferich, A. M., Grube, A., & Simon, R. P. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107346 · Cited by 1
The Effect of FcRn Binding on Ocular Disposition of Monoclonal Antibodies
Naware, S., Kulkarni, S. P., Salvi, S., Patel, D., & Shah, D. K. (2026) · Antibodies · doi:10.3390/antib15020027 · Cited by 1
“Notably, conjunctival endothelial cells lack blood–retinal barrier-like tight junctions, and hence FcRn expressed in conjunctival lymphatic vessels is hypothesized to mediate the efflux of IgG or antigen-IgG complexes from the conjunctival space [9].”
InfluentialBernat‐Just, L., Ta, P. L., Sebastián-Morelló, M., Rodilla, V., López‐Castellano, A., & Alambiaga‐Caravaca, A. M. (2026) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2026.107541 · Cited by 1
Focused Ultrasound Treatment of Vitreous Hemorrhage in an In Vivo Rabbit Model
Yau, G. L., Ning, B., Hu, C., & Hynynen, K. (2026) · Ophthalmology Science · doi:10.1016/j.xops.2026.101188 · Cited by 1
“In accordance with standardized rabbit eye histology procedures, 39 — 41 the enucleated samples were firstly fixed in 10% formalin for 15 minutes, before removing the cornea and the iris using iris scissors.”
Lin, K., Cabral, P., Ekpenyong, O., Bader, S. E., Galvão, J., Kim, Y., Lu, S. X., Tam, Y. T., Bruder, M., Rearden, P., et al. (2020) · Toxicologic Pathology · doi:10.1177/0192623320948836 · Cited by 1
“The intravitreal injection procedure was adapted from previous literature.(22) Rabbits were anesthetized with a cocktail of ketamine (25 mg/kg) and xylazine (5 mg/kg), and topical 0.”
MethodTrypsin dose optimization for glaucoma induction in rabbit model
Muharib, N. M., & Al-Timmemi, H. A. K. (2021) · Al-mağallaẗ al-ʻirāqiyyaẗ li-l-ʻulūm al-bayṭariyyaẗ/Iraqi journal of veterinary sciences · doi:10.33899/ijvs.2021.131748.2001 · Cited by 1
“pharmacokinetic therapies of eye diseases furthermore the adequate size of eye ball that create easy handling (3).”
BackgroundVenkatesh, S., & Richardson, M. (2023) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2023.0050 · Cited by 1
Volumes and routes of drug administration into different structures of the eye in laboratory animals
Kukushkina, E. S., Макарова, М. Н., & Matichin, A. A. (2025) · Laboratornye Zhivotnye dlya nauchnych issledovanii (Laboratory Animals for Science) · doi:10.57034/2618723x-2025-01-06 · Cited by 1
EXPERIMENTAL TESTING OF THE MODIFIED METHOD OF INTRAVITREAL INJECTION IN THE RABBIT EYE
Kalatanova, A. V., Katelnikova, A. E., Макарова, М. Н., & Makarov, V. G. (2018) · The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation · doi:10.30895/1991-2919-2018-8-2-109-114
“Методика ИВИ кроликам изложена только в зарубежных статьях [13, 14], однако предложенные методики анестезии, анальгезии и выбор ЛС для офтальмологического применения при воспроизведении в России требуют адаптации.”
Altaey, O. Y., & Al-Haaik, A. G. (2023) · European Journal of Theoretical and Applied Sciences · doi:10.59324/ejtas.2023.1(4).24
Abiyoga, K., Primitasari, Y., & Lutfi, D. (2023) · Bali Medical Journal · doi:10.15562/bmj.v12i2.4339
Impact of Several Drugs on the Rabbit Eye
Rattan, S. K., Meena, K. P., & Vaishnav, V. A. D. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898812195125010011
A generic technology for long-acting intravitreal therapyPreprint
Santi, D. V., Hoshi, S., Schneider, E. L., Oota-Ishigaki, A., Oshika, T., Fernandez, R., & Hails, G. (2026) · Research Square · doi:10.21203/rs.3.rs-8408708/v1
A Welfare Assessment Tool to Harmonize Care and Management for Research Rabbits
O’Malley, C. I., Thurston, S. E., & Nunamaker, E. A. (2026) · Animals · doi:10.3390/ani16081229
Metadata
- Authors
- Ahn, S. J., Hong, H. K., Na, Y. M., Park, S. J., Ahn, J., Oh, J., Chung, J. Y., Park, K. H., & Woo, S. J.
- Affiliations
- Seoul National University (KR)
- Seoul National University Bundang Hospital (KR)
- Seoul National University Hospital (KR)
- Venue
- Journal of Visualized Experiments
- Publisher
- MyJove Corporation
- Published
- 2016-07-23
- Issue
- 113
- ISSN
- 1940-087X (ISSN-L)
- PMC
- PMC5091672
- OpenAlex
- W2476883165
- Cited by
- 60
- References
- 42
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 7 · 2023: 13 · 2022: 6 · 2021: 9 · 2020: 7 · 2019: 1 · 2018: 4 · 2017: 1
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Visualized Experiments (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Seoul National University Bundang Hospital
- Seoul National University Hospital
- National Research Council of Science and Technology
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- rabbit eye, intraocular drug delivery, pharmacokinetics, intravitreal injection, intracameral injection, vitreous humor, aqueous humor, pharmacokinetic modeling, ocular drug concentration
- MeSH terms
- Animals, Aqueous Humor, Choroid, Pharmaceutical Preparations, Humans, Pharmacokinetics, Rabbits, Retina, Vitreous Body, Injections, Intraocular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.